SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-384895
Filing Date
2014-10-28
Accepted
2014-10-28 15:09:33
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d798950d10q.htm 10-Q 925470
2 EX-10.1 d798950dex101.htm EX-10.1 58909
3 EX-31.1 d798950dex311.htm EX-31.1 8352
4 EX-31.2 d798950dex312.htm EX-31.2 8378
5 EX-32.1 d798950dex321.htm EX-32.1 3398
  Complete submission text file 0001193125-14-384895.txt   9087895

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20140930.xml EX-101.INS 1678580
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20140930.xsd EX-101.SCH 60400
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20140930_cal.xml EX-101.CAL 122124
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20140930_def.xml EX-101.DEF 439197
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20140930_lab.xml EX-101.LAB 540781
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20140930_pre.xml EX-101.PRE 513303
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 141176924
SIC: 2834 Pharmaceutical Preparations